Raju Prasad
Net worth: 874 442 $ as of 2026-05-30
Net worth: 874 442 $ as of 2026-05-30
Raju Prasad is currently Chief Financial & Accounting Officer at CRISPR Therapeutics AG since 2023.
Formerly, Dr. Prasad was a Research Analyst at William Blair & Co. LLC from 2014 to 2023 and a Research Associate at the University of North Carolina at Chapel Hill.
Education includes an undergraduate degree from Rutgers State University of New Jersey, a graduate degree from the University of Delaware, and a doctorate from The University of North Carolina at Charlotte.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-05-28 | 15,565 ( 0.02% ) | 874 442 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| CRISPR THERAPEUTICS AG | Director of Finance/CFO | 2023-03-13 |
| Companies | Position | End |
|---|---|---|
William Blair & Co. LLC
William Blair & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 2023-02-28 |
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
William Blair & Co. LLC
William Blair & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Rutgers State University of New Jersey
Rutgers State University of New Jersey Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Delaware
University of Delaware Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of North Carolina at Charlotte
The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CRISPR Therapeutics AG
CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
University of North Carolina at Chapel Hill
University of North Carolina at Chapel Hill Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Select your edition
All financial news and data tailored to specific country editions